The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.

Novo Nordisk, which manufactures weight-loss drug Wegovy and diabetes medication Ozempic, has asked the US authorities to ...

来自礼来(LLY.US)为期三年的第三阶段临床研究SURMOUNT-1的更详细结果显示，其肥胖药物Wegovy和2型糖尿病药物Ozempic中的活性成分替尔泊肽(tirzepatide)可持续带来减重及糖尿病方面的益处。 三年后，服用15毫克剂量(测试中最高的剂量)的人平均体重持续下降22.9%。 在所有三种剂量的测试中，与安慰剂对照组相比，替尔泊肽与降低94%糖尿病进展风险具有相关性。 参加试验 ...

Stopping semaglutide, marketed as Wegovy and Ozempic, which helps people lose weight , can have severe health impacts, a new ...

A new study found that popular weight loss and obesity drugs, Ozempic and Wegovy can help people cut back on drinking. The ...

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking.That's according to new research published by JAMA Psychiatry.In a study of around 228,000 people in Sweden who had ...

据港交所文件，11月13日，杭州九源基因工程股份有限公司通过港交所上市聆讯。据文件披露，于2024年6月18日，诺和诺德用于治疗超重及肥胖症的司美格鲁肽产品Wegovy（诺和盈）在中国获得批准，这可能会对公司的JY29-2（吉可亲）造成竞争。由于预期的竞争，公司计划就JY29-2（吉可亲）与Wegovy进行对比研究，作为其评估JY29 ...

The weight loss drugs Ozempic and Wegovy may be beneficial for people struggling with alcohol addiction, a study published ...

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...